GS-3 · 2) PDS (objectives, functioning, limitations, revamping, issues of buffer stocks & food security)

201815 marksQ11Biopharma Advancements

Why is there so much activity in the field of biotechnology in our country? How has this activity benefitted the field of biopharma?